Back

Boston Scientific Corp

Ticker: BSX ISIN: US1011371077
Add to portfolio Portfolio analysis in 2min
Stock Large-cap
Market cap
$83.24B
P/E
23.43
Forward P/E
16.61
Profit margin
17.29%
Revenue growth QoQ
11.60%
Beta
0.62
$49.01 -2.70%
Price as of 2026-08-24 · NYSE

Performance by timeframe

Rolling returns
1 Month +7.69%
6 Months -34.78%
1 Year -53.37%
5 Years +1.88% p.a.+9.74%
10 Years +7.27% p.a.+101.69%
Since inception +6.77% p.a.+413.19%
Calendar year returns
YTD -48.60%
2025 +6.75%
2024 +54.51%
2023 +24.94%
2022 +8.92%
2021 +18.16%

Key stats

Market cap
83.24B
P/E
23.43
Beta
0.62
52-week range
54.98 - 109.50
50-day MA
65.84
200-day MA
89.28
Section 1

Business overview

Company profile data from fundamentals.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 14.66%
ROA 6.07%
Profit margin 17.29%
Operating margin 20.60%
PEG ratio 0.68
Revenue/share TTM 13.91
Revenue TTM 20.61B
EBITDA 5.50B
Gross profit TTM 14.21B
Beta 0.62

Valuation

Trailing P/E 23.43
Forward P/E 16.61
P/B 3.22
P/S 4.04
EV/EBITDA 16.89
EV/Revenue 4.50

ESG Scores

Total ESG 29.2
Environment 1.5
Social 12.9
Governance 7.9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 3.38
Quarterly earnings growth 100.00%
Revenue TTM 20.61B
Reported quarters 119
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0.00%
Split factor 2:1
Last split date 2003-11-06
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $117.02
Analyst rating 4.5882

Ownership & short interest

Shares outstanding 1.48B
Shares float 1.48B
Institutional ownership 93.65%
Insider ownership 18.80%
Short ratio 1.66
Short % of float 1.73%

Details

Instrument metadata and source update timestamps.

Symbol BSX
Name Boston Scientific Corp
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US1011371077
Country USA
Code + exchange BSX.NYSE
Fundamentals updated 2026-05-07

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.